Open Access

Expression of genes related to the hypothalamic-pituitary-adrenal axis in murine fetal lungs in late gestation

Reproductive Biology and Endocrinology20108:134

https://doi.org/10.1186/1477-7827-8-134

Received: 6 July 2010

Accepted: 4 November 2010

Published: 4 November 2010

Abstract

Background

Lung maturation is modulated by several factors, including glucocorticoids. Expression of hypothalamic-pituitary-adrenal (HPA) axis-related components, with proposed or described local regulatory systems analogous to the HPA axis, was reported in peripheral tissues. Here, HPA axis-related genes were studied in the mouse developing lung during a period overlapping the surge of surfactant production.

Methods

Expression of genes encoding for corticotropin-releasing hormone (CRH), CRH receptors (CRHR) 1 and 2beta, CRH-binding protein, proopiomelanocortin (POMC), melanocortin receptor 2 (MC2R), and glucocorticoid receptor was quantified by real-time PCR and localized by in situ hydridization in fetal lungs at gestational days (GD) 15.5, 16.5, and 17.5, and was also quantified in primary mesenchymal- and epithelial cell-enriched cultures. In addition, the capability of CRH and adrenocorticotropic hormone (ACTH) to stimulate pulmonary expression of enzymes involved in the adrenal pathway of glucocorticoid synthesis was addressed, as well as the glucocorticoid production by fetal lung explants.

Results

We report that all the studied genes are expressed in fetal lungs according to different patterns. On GD 15.5, Mc2r showed peaks in expression in samples that have previously presented high mRNA levels for glucocorticoid synthesizing enzymes, including 11beta-hydroxylase (Cyp11b1). Crhr1 mRNA co-localized with Pomc mRNA in cells surrounding the proximal epithelium on GD 15.5 and 16.5. A transition in expression sites toward distal epithelial cells was observed between GD 15.5 and 17.5 for all the studied genes. CRH or ACTH stimulation of genes involved in the adrenal pathway of glucocorticoid synthesis was not observed in lung explants on GD 15.5, whereas CRH significantly increased expression of 21-hydroxylase (Cyp21a1) on GD 17.5. A deoxycorticosterone production by fetal lung explants was observed.

Conclusions

Temporal and spatial modulations of expression of HPA axis-related genes in late gestation are consistent with roles for these genes in lung development. Our data are likely to lead to valuable insights in relation to lung diseases originating from lung immaturity.

Background

Corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) are classically involved in the modulation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to secretion of glucocorticoids by the adrenal glands [1, 2]. CRH also has a role in regulating neuroendocrine functions, reproduction, and immune functions [3]. The proopiomelanocortin (Pomc) gene encodes for several peptides with various roles, including ACTH, with highly tissue-specific regulation and processing [4, 5]. During gestation, glucocorticoids of adrenal origin are involved in the maturation of many fetal organ systems, including the lung [6, 7]. Glucocorticoids are administered to pregnant women at risk of premature delivery to accelerate fetal lung maturation and to reduce the occurrence and severity of respiratory distress syndrome (RDS) [8]. Their importance in fetal lung development was highlighted by CRH-null and glucocorticoid receptor (GR)-null mouse models, in which mice display an abnormal lung phenotype and die at birth from respiratory failure [9, 10].

Limited information is available on expression of CRH, ACTH, and other HPA axis-related components in the fetal lung. Crh mRNA was localized in fetal mouse lungs around branching bronchioles [11], CRH was detected in baboon fetal lungs [12], and POMC mRNA was detected in ovine fetal lungs [13]. A direct effect of CRH was demonstrated on differentiation and proliferation of type II pneumocytes in baboon fetal lung explants [14]. CRH receptor type 1 (CRHR1), which is associated with pituitary ACTH secretion, was detected at the mRNA level in baboon fetal lungs [14]. In addition, the melanocortin 2 receptor (MC2R), which leads to glucocorticoid production in adrenal glands following binding to its only known ligand ACTH [5], was detected in developing mouse lungs [15].

Expression of Crh and Pomc was shown in several peripheral tissues [5, 16], including thymus [17, 18] and skin [19]. In the latter, CRH/ACTH signaling was reported, leading to local glucocorticoid production. Brain, cardiovascular system, and thymus were also identified as production sites of glucocorticoids involving an adrenal-like enzymatic pathway [20, 21]. However, the implication of CRH and ACTH in these glucocorticoid productions remains to be defined. Our laboratory previously reported that genes involved in the adrenal pathway of glucocorticoid synthesis, namely steroidogenic acute regulatory protein (Star), cytochrome P450 side chain cleavage (Cyp11a1), 3β-hydroxysteroid dehydrogenase (Hsd3b1), 21-hydroxylase (Cyp21a1), and 11β-hydroxylase (Cyp11b1), are transiently co-expressed at high levels in the fetal mouse lung on gestational day (GD) 15 [22]. Whether this co-expression is modulated by pituitary ACTH, by an autocrine/paracrine mechanism involving a local HPA axis-like pathway, or by a CRH/ACTH-independent mechanism, remains to be determined.

Based on data showing 1) the expression of HPA axis-related genes in some peripheral tissues, 2) the existence of a functional HPA axis-like pathway leading to glucocorticoid production in the skin, and 3) the transient expression of genes involved in the adrenal pathway of glucocorticoid synthesis in the murine fetal lung, we hypothesized that HPA axis-related genes could be developmentally regulated in the murine fetal lung and that CRH and/or ACTH could be involved in the regulation of fetal pulmonary expression of enzymes leading to glucocorticoid production. In order to question their involvement in lung development, HPA axis-related genes were studied in the developing lung where their expression profiles as well as their sites of expression were investigated. For that purpose, Crh, Crhr1, Crhr2b, Crhbp, Pomc, Mc2r, and Nr3c1 (GR) were studied by QPCR and in situ hybridization in male and female fetal mouse lungs on GD 15.5, 16.5, and 17.5. This gestation window overlaps the surge of surfactant production occurring on GD 17.5 [2325]. Immunoreactive ACTH (iACTH) was also detected by immunohistochemistry. The existence of a male disadvantage in the occurrence of RDS [26], as well as the proposed transient delay for one sex in the expression of genes involved in glucocorticoid synthesis in the developing lung [22], warranted the consideration of sex. Several adult tissues including lung, spleen, thymus, brain, and adrenal gland were included in QPCR experiments for comparison. Messenger RNA levels were also measured in epithelial cell-enriched and fibroblast-enriched primary cultures originating from mouse fetal lungs to further characterize expression profiles of the target genes. In addition, fetal lung explants were incubated in the presence of CRH or ACTH to evaluate the capability of these hormones to stimulate the expression of Pomc, Star, Hsd3b1, Cyp21a1, and Cyp11b1, and the glucocorticoid production by fetal lung explants was addressed.

Methods

Animals, housing, and fetal tissue preparation

Protocol was approved by the Animal Care and Use Committee and the Institutional Review Board of the CHUQ Research Ctr (protocol no. 2008-071). BALB/c mice (Mus musculus) aged 63-70 days and certified pathogen-free were purchased (Charles River Laboratories, St-Constant, QC, Canada) and housed in a room maintained at 22°C, 50% relative humidity and on a 12-hours cycle (07:15-19:15 hours) of fluorescent lighting (300 Lux). Global 18% Protein Rodent Diet (Teklad, Montréal, QC, Canada) and tap water were provided ad libitum. New animals were acclimatized to these conditions for 7-14 days prior to be mated. Fetuses were obtained from overnight periods of mating. The day of vaginal plug was considered as GD 0.5. Pregnant females were sacrificed by exposure to a CO2 atmosphere. Fetal sex was visually established and confirmed in some cases by PCR amplification of Sry as previously described [27]. Lungs were rinsed thoroughly in phosphate buffered saline (PBS) and snap-frozen before storage at -80°C, or put in 4% w/v paraformaldehyde for 48 hours and then paraffin-embedded. Slices of 5 μm were prepared for in situ hybridization and immunohistochemistry experiments. A minimum of three litters, including females and males, were studied on GD 15.5, 16.5, and 17.5.

RNA probes

RNA probe templates were prepared from mouse lung and brain cDNAs, as previously described [28]. Briefly, a specific fragment of each studied gene was amplified and inserted into pGEM-4Z (Promega Corp., Madison, WI, USA). Specific primer pairs used for PCR amplifications are presented in Table 1. Antisense and sense RNA probes were synthesized using DIG-UTP substrate (Roche Diagnostics, Laval, QC, Canada) from PCR products amplified with specific primers for SP6 and T7 promoters: GGATTTAGGTGACACTATAGAATA and TAATACGACTCACTATAGGGAGAC, respectively.
Table 1

Oligonucleotides and experimental parameters for QPCR, and oligonucleotides for in situ hydridization probe synthesis, for experiments in mouse fetal lungs

Genesa(NCBI)

Oligonucleotidesb

Amplicon length (bp)

QPCR conditionsc

 

QPCR: forward/reverse RNA probes: forward /reverse

Probe position

Ann. T°C

Acq. T°C

# of cycles

 

Target genes

Pomc (NM_008895)

CATTAGGCTTGGAGCAGGTC/TCTTGATGATGGCGTTCTTG

174

66

88

45

 

ACGTGGAAGATGCCGAGATTCTGCTACAGTC/CAGGAACAGCAGCAGTGC

141-433

   

Mc2r (NM_008560)

CCTCTCTTTGCTGGGCTCTA/GCACCCTTCATGTTGGTTCT

321

63

83

40

 

CCTCTCTTTGCTGGGCTCTA/GCACCCTTCATGTTGGTTCT

589-909

   

Crh (NM_205769)

CCTGGGGAATCTCAACAGAA/AACACGCGGAAAAAGTTAGC

120

62

89

45

 

TCCGCATGGGTGAAGAATAC/GGTGGAAGGTGAGATCCAGA

347-649

   

Crhbp (NM_198408)

TCTTACCAGAAGGAGCATCAG/GTGTCCGAGGGTAAGATCAG

241

63

81

45

 

CGGGGATTTCCTGAAGGTAT/CTGCAGTTTTGGTGCTGGTA

469-768

   

Crhr1 (NM_007762)

CCAGGATCAGCAGTGTGAGA/TGTTGTAGCGGACACCGTAG

161

64

86

43

 

CCAGGATCAGCAGTGTGAGA/AGTGGCCCAGGTAGTTGATG

265-372

   

Crhr2b (NM_009953)

CAGGCCAGGCACCCCAGGAC/GGAACCACGCGATGTTTCTCAG

477

68

85

43

 

GGCTTTACCTTGGTGGGTAG/TGAAAAATTCCCAGTTGTGGTC

162-492

   

Nr3c1 (NM_008173)

GGGGAATTCACAGACTTTCGGCTTCTGGA/GGGAAGCTTCTGACCTCCAAGGACTCTCG

297

63

83

40

 

ACCTGGATGACCAAATGACC/AGGAGAGAAGCAGTAAGGTTTTCA

1821-2078

   

Mrap (NM_029844)

TTCGTGGTGCTCCTCTTTCT/TCCTGGCTCCTCTGTTGTCT

162

63

85

43

Cyp21a1 (NM_009995)

CCTTGCCCCATCGTGCAACTA/TGGAGGCAGCAGAGTGAAGG

278

67

85

43

Vim (NM_011701)

GATCAGCTCACCAACGACAA/AAGACGTGCCAGAGAAGCAT

170

62

84

40

Krt18 (NM_010664)

GTGGAATCCAGACCGAGAAA/GTTCTTCCTTGAGTGCCTCG

406

58

84

40

 

Housekeeping genes

Gapdh (NM_008084)

GTCGGTGTGAACGGATTTG/AAGATGGTGATGGGCTTCC

215

61

84

40

Hprt1 (NM_013556)

AGTCCCAGCGTCGTGATTAG/AATCCAGCAGGTCAGCAAAG

228

64

82

40

Sdha (BC031849)

ACACAGACCTGGTGGAGACC/CAAACGGCTTCTTCTGCTGT

179

59

84

45

aPomc, proopiomelanocortin; Mc2r, melanocortin receptor 2 (ACTH receptor); Crh, corticotropin releasing hormone; Crhbp, corticotropin releasing hormone binding protein; Crhr1, corticotropin releasing hormone receptor 1; Crhr2b, corticotropin releasing hormone receptor 2β; Nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor); Mrap, melanocortin2 receptor accessory protein; Cyp21a1, 21-hydroxylase; Vim, vimentin; Krt18, keratin 18; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Hprt1, hypoxanthine phosphoribosyltransferase 1; Sdha, succinate dehydrogenase complex, subunit A, flavoprotein.

bPrimer pairs used in QPCR experiments are presented. Primer pairs used to amplify and clone specific fragments to be used in RNA probe synthesis are underlined. Primer pairs for cloning contain sequences for restriction endonucleases: forward primers, GGGGAATTC; reverse primers, GGGAAGCTT.

cAnn. T°C = annealing temperature; Acq. T°C = acquisition (fluorescence intensity reading) temperature.

In situ hybridization and immunohistochemistry

In situ hybridization was performed as previously described [28]. Hybridization with specific RNA probes (5 ng/ul) was performed overnight at 42°C. Tissue sections were incubated in substrate solution [28] three hours for Crh, Pomc, and Nr3c1 or overnight for Crhr1, Crhr2b, Crhbp, and Mc2r. Immunohistochemistry was performed as previously described [28]. The anti-immunoreactive ACTH (iACTH) antibody (rabbit anti-mouse; kindly provided by Dr Georges Pelletier, CHUQ Research Ctr, [29]) and a rabbit IgG preparation (Vector Laboratories Inc, Burlington, ON, Canada) were incubated overnight at 4°C. Microscopy was performed with a Zeiss Axioskop 2 Plus microscope (Carl Zeiss Canada, Toronto, ON, Canada) equipped with Zeiss Plan-Neofluar objectives. Images were acquired with a QImaging Retiga 2000R camera (QImaging, Surrey, BC, Canada) using the Image-Pro Plus 5.1 software (Media Cybernetics Inc, Bethesda, MD, USA).

Quantitative real-time PCR and normalization with multiple housekeeping genes

RNA extraction and cDNA synthesis [30], and quantitative real-time PCR [31], were performed as described previously. The analyzed genes and quantitative real-time PCR conditions are presented in Table 1, except for Star, Hsd3b1, and Cyp11b1 [22]. After enzyme activation (10 min, 95°C), PCR cycles were performed: 5 sec, denaturation 95°C; 5 sec, annealing (see Table 1 for temperature); 20 sec, elongation 72°C; 5 sec, temperature of fluorescence intensity reading (see Table 1). Expression stability of three housekeeping genes (Gapdh, Hprt1, Sdha) was assessed based on the approach proposed by Vandesompele et al [32]. Then, normalization factors were calculated from expression levels of the three housekeeping genes.

Preparation of fibroblast- and epithelial cell-enriched cultures from fetal mouse lungs

Fetal lungs were removed, rinsed in PBS, cut into pieces of approximately 2 mm3, and extensively rinsed again in PBS. Digestion was made in Hank's buffered saline solution (HBSS) (Multicell, Wisent Inc., St-Bruno, QC, Canada) containing 0.25% w/v trypsin (Multicell), 0.17% w/v collagenase (Sigma, St. Louis, MO, USA), DNAse I (25 μg/ml) (Sigma), penicillin (50 iu)/streptomycin (50 μg/ml) (Multicell), and gentamycin (5 μg/ml) (Sigma) at 37°C for 30 minutes under agitation. Digestion was stopped by addition of Dulbecco's modified eagle's medium (DMEM) (Multicell) containing 20% v/v fetal bovine serum (FBS) (Sigma). Residual tissue debris were discarded by 1 × g sedimentation and then, supernatants were centrifuged 7 min at 100 × g. Cell pellets were resuspended in DMEM containing 20% v/v FBS and penicillin (50 iu)/streptomycin (50 μg/ml). Cells were incubated for one hour at 37°C with 5% CO2 to allow fibroblast adhesion. Then, culture media were removed and the fibroblast adhesion step was repeated twice. The epithelial cell-enriched fractions (non-adherent cells) were collected and filtered through a sterile 45 μm cell strainer (VWR International, Montréal, QC, Canada), centrifuged 7 min at 100 × g and then plated in 12-well plates. Cell cultures were kept 12 hours at 37°C under 5% CO2 atmosphere. Cell phenotypes were visually confirmed before harvesting. Epithelial cell-enriched cultures were then homogenized in TRI Reagent (Molecular Research Center, Cincinnati, OH, USA) for RNA extraction. Fibroblast-enriched cultures were filtered through a sterile 45 μm cell strainer before RNA extraction. Three separate cell enrichment experiments with 2-3 litters each were done at GD15.5 (total n = 44 fetal lungs) and four were done at GD17.5 (total n = 42 fetal lungs). Given the low number of epithelial cells recovered at GD15.5, RNA extracts were pooled before cDNA preparation. At GD17.5, enough epithelial cells for cDNA synthesis were recovered in 2 out of 4 experiments.

Incubation of lung explants with CRH or ACTH

GD 15.5 and 17.5 fetal lungs were removed, rinsed in PBS, and incubated 8 h in DMEM containing penicillin (50 iu)/streptomycin (50 μg/ml) and 10-7 M CRH (C3042, Sigma) or 10-7 M ACTH (Cortrosyn, Amphastar Pharmaceuticals Inc., Rancho Cucamonga, CA, USA) at 37°C under gentle agitation. Three and four litters were analyzed at GD 15.5 and 17.5, respectively, with 1 to 3 fetal lungs per condition (control, CRH, and ACTH) for each litter. Explants were then homogenized in TRI reagent and stored at -80°C until RNA extraction.

Steroidogenic activity measures

Deoxycorticosterone (DOC) production was measured in control and CRH-treated-GD17.5 lung explants. Five litters were used, with 2-3 fetal lungs per litter per condition. The explants were incubated in 1 mL of DMEM containing pen/strep a first 3 h with 2 × 10-7 M CRH or without, then 5 h with 2 × 10-7 M CRH or without in the presence of [1,2,6,7-3H(N)]progesterone at 58 nM (6 μCi/well) (Perkin Elmer, Boston, MA) and unlabeled DOC (Steraloids, Wilton, NH) at 10-5 M. Unlabeled DOC was added to reduce metabolization of tritiated DOC. Steroids were extracted from culture media with chlorobutane, and resolved by thin layer chromatography (toluene 78: acetone 20: methanol 2). Tritiated standards of progesterone, DOC, and corticosterone were included. Revelation of the tritiated products and quantification were performed using a Storm apparatus (Molecular Dynamics, Inc., Sunnyvale, CA). Data are expressed as deoxycorticosterone radioactivity count/total radioactivity count/mg tissue.

Statistical analysis

Statistical analyses were performed using GraphPad Prism 5.01 software (GraphPad Software, La Jolla, CA, USA). Two-way ANOVA with randomized-block design was used for QPCR experiments on total fetal lung extracts, where male and female values were matched. One-way ANOVA with randomized-block design followed by a Tukey's test was used for experiments with lung explants incubated with CRH or ACTH, where samples from the same litter were matched. Paired t-test was used to analyze data of deoxycorticosterone quantification, where mean control samples and mean treated samples from each litter were paired. When normality of data could not be assumed following a normality test in GraphPad Prism, logN transformation was performed. A difference with a P value of less than 0.05 was considered as significant.

Results

Expression levels of HPA axis-related genes in male and female fetal mouse lungs

The gene expression profiles of Crh, Crhbp, Crhr1, Crhr2b, Pomc, Mc2r, and Nr3c1 were determined in male and female fetal lung pools from several mouse litters collected on GD 15.5, 16.5, and 17.5 (Figure 1). Several mature tissues were included for reference. To give estimates of raw mRNA levels in fetal lungs, mean crossing point values are presented in Table 2.
Figure 1

Relative mRNA expression levels of HPA axis-related genes in mouse fetal lungs. Crh (A), Crhbp (B), Crhr1 (C), Crhr2b (D), Pomc (E), Mc2r (F), and Nr3c1 (G) were quantified by QPCR in male and female total fetal lung extracts from several litters on GD 15.5, 16.5, and 17.5. For each litter, the black bar represents the male pool and the white bar represents the female pool. Dashed bars represent adult tissues. Number of animals in each litter (litter #: number of males (M), number of females (F)): #1: 2 M, 2 F; #2: 4 M, 5 F; #3: 4 M, 3 F; #4: 2 M, 3 F; #5: 3 M, 6 F; #6: 4 M, 3 F; #7: 1 M, 2 F; #8: 4 M, 4 F; #9: 3 M, 4 F; #10: 3 M, 1 F. Each value (± SD) was normalized using a factor generated from expression values of three housekeeping genes, namely Hprt1, Sdha, and Gapdh. ANOVA was performed to evaluate the effect of time and sex. A trend in increase in Crh mRNA levels was observed according to gestation time (p = 0.053) (A), a significant interaction between time and sex (p = 0.019), as well as a significant impact of sex (p = 0.017), were observed for Crhbp mRNA levels (B), and a significant increase in Nr3c1 mRNA levels was observed over time (p = 0.0003) (G).

Table 2

Mean crossing point (cp) values of the amplified genes in mouse fetal lungs

 

Target genes

Housekeeping genes

 

Crh

Crhbp

Crhr1

Crhr2b

Pomc

Mc2r

Nr3c1

Mrap

Hprt1

Sdha

Gapdh

Mean cp ± SDa

36.03 ± 1.49

35.58 ± 1.92

35.49 ± 1.35

32.68 ± 1.50

35.13 ± 1.24

33.46 ± 2.06

24.05 ± 1.98

32.87 ± 0.64

23.15 ± 1.45

24.10 ± 1.43

17.86 ± 0.70

aMean crossing points (cp) ± SD were calculated using GD 15.5, 16.5, and 17.5 mouse fetal lungs. The values are estimations of the relative abundance of the indicated mRNAs (n = 16-20 pools). Samples in which no expression was detected were not included. The lower value, the higher mRNA abundance.

Crh mRNA levels were higher in fetal lung samples than in other tissues, including total brain (Figure 1A). In addition, a trend in increase in Crh mRNA levels was observed according to gestation time (p = 0.053). For Crhbp mRNA levels (Figure 1B), a significant interaction between time and sex (p = 0.019), as well as a significant impact of sex (p = 0.017), were observed. Moreover, expression levels tend to decrease according to gestational age. A high Crhbp mRNA level was detected in brain, which is recognized as the major expression site of this gene [33]. Very low levels of Crhr1 mRNA were observed in several fetal lung samples (Figure 1C; Table 2), while no expression was detected in the others. For comparison, brain and spleen expressed Crhr1 mRNA at relatively high levels, and no expression was detected in adult lung and adrenal gland. Crhr2b expression in fetal lung samples showed more interindividual variability than the other considered genes (Figure 1D), but no significant effect of time or sex was observed. A higher mRNA level was detected in adult lung than in the other control tissues. Pomc mRNA levels were similar between fetal lungs and adult tissues, except for adrenal gland in which expression level was very low (Figure 1E). Mc2r mRNA was detected in fetal lungs and was found to be expressed at much higher levels in two GD 15.5 samples (one female pool and one male pool) (Figure 1F). These two samples were previously shown to express high levels of genes involved in the adrenal glucocorticoid synthesis pathway (samples 70 F and 71 M in [22]). As expected, the expression level of Mc2r in adrenal gland was very high. No significant effect of time or sex was observed for Pomc and Mc2r. Gene expression of melanocortin receptor associated protein (MRAP), which is important in MC2R signaling [34], was also detected in fetal lung samples (Table 2 and data not shown). High Nr3c1 mRNA levels were detected in fetal lungs (Table 2) and a significant increase in expression was observed over time (about 2-fold between GD 15.5 and 17.5, p = 0.0003) (Figure 1G). Among the analyzed mature tissues, the highest Nr3c1 expression level was observed in the lung.

Expression sites of HPA axis-related genes in male and female fetal mouse lungs

In situ hybridization was performed on male and female fetal mouse lungs from GD 15.5, 16.5, and 17.5 to localize expression sites of Crh, Crhbp, Crhr1, Crhr2b, Pomc, Mc2r, and Nr3c1 (Figures 2, 3, and data not shown). In addition, iACTH was detected by immunohistochemistry (Figure 2).
Figure 2

Distribution of Crhr1 mRNA, Pomc mRNA, and immunoreactive (i) ACTH protein in mouse fetal lungs. Tissue sections are from GD 15.5 (A, B, F, G, K and L), 16.5 (C, H and M) or 17.5 (D, I and N). Adult mouse pituitary sections are used as positive control (E, J and O). In situ hybridization was performed using anti-sense probes (A to J, positive signal is blue), while immunohistochemistry was performed using an anti-iACTH polyclonal antibody (K to O, positive signal is red). No staining was observed using corresponding sense probes (negative controls, data not shown). On GD 15.5, expression of Crhr1 (A and B) and Pomc (F and G) was observed in cells surrounding airways and a change in expression sites toward distal epithelial cells was observed according to developmental time. On GD 15.5 (K and L), 16.5 (M), and 17.5 (N), iACTH was detected in epithelial cells. Scale bars, 100 μm (A, E, F, J, K and O) or 50 μm (B to D, G to I and L to N). AL, anterior lobe; CZ, conducting zone; E, epithelial cells; EC, endothelial cells; IL, intermediary lobe; M, mesenchyme; PL, posterior lobe; RZ, respiratory zone; SM, smooth muscle.

Crhr1 and Pomc mRNAs were localized on GD 15.5 and 16.5 in cells surrounding epithelial cells of conducting zones (Figure 2A-C, F-H), whereas iACTH protein was detected in epithelial cells (Figure 2K-M). On GD 17.5, Pomc and iACTH signals were strong in epithelial cells of distal zones (Figure 2I and 2N). Adult pituitary gland was used as positive control and, as expected, Crhr1, Pomc, and iACTH were localized in intermediate and anterior lobes (Figure 2E J, and 2O) [35].

For Crh, Crhbp, Crhr2b, Mc2r, and Nr3c1 mRNAs, positive signals were widely distributed on GD 15.5 (Figure 3A, C, E, G, and 3I) and 16.5 (data not shown). However, no signal was observed in epithelial cells of conducting zones, except for a few cells. For these five genes, as for Crhr1 and Pomc, an important change in expression sites is observed when tissues originating from GD 15.5-16.5 and GD 17.5 are compared, the distal epithelium being the major site of expression on GD 17.5 (Figure 3B, D, F, H, and 3J). Nr3c1 mRNA was also detected in mesenchymal cells, although at lower levels than in epithelial cells. For every gene studied, no sex difference was observed in mRNA expression sites.
Figure 3

Distribution of Crh , Crhbp , Crhr2b , Mc2r , and Nr3c1 mRNAs in mouse fetal lungs. Mouse tissue sections are from GD 15.5 (A, C, E, G and I) or 17.5 (B, D, F, H and J). In situ hybridization was performed using anti-sense probes (A to J, positive signal is blue). No staining was observed using corresponding sense probes (negative controls, data not shown). Results obtained on GD 16.5 (data not shown) are similar to those obtained on GD 15.5 for all the genes. A change in expression sites between GD 15.5-16.5 versus 17.5 was observed. Expression of mRNAs encoding for all the analyzed genes was observed in epithelial cells of distal zones on GD 17.5. Scale bars, 50 μm (A to J). CZ, conducting zone; E, epithelial cells; EC, endothelial cell; M, mesenchyme; RZ, respiratory zone; SM, smooth muscle.

Expression levels of HPA axis-related genes in primary cell cultures derived from fetal mouse lungs

Next, we determined whether the transition in gene expression sites from GD 15.5 to 17.5 can be observed in cell cultures. Levels of Crh, Crhbp, Crhr1, Crhr2b, Pomc, Mc2r, and Nr3c1 mRNAs were compared between fibroblast-enriched cell cultures, epithelial cell-enriched cell cultures, and total lungs. Fetal sex was not considered in these experiments because only Crhbp showed a sex difference in expression by QPCR in whole lungs, whereas no sex difference was observed for any of these genes by in situ hybridization. Messenger RNA levels of Krt18 and Vim, which are epithelial and mesenchymal markers, respectively, confirmed cell enrichments (Figure 4C). For each analyzed gene, ratios corresponding to mRNA levels in epithelial cell-enriched cultures over those in fibroblast-enriched cultures are presented in Figure 4D. Interestingly, Crh mRNA was not or barely detected in cell cultures. On GD 15.5 and 17.5, Crhr1 mRNA was detected in mesenchymal cells, whereas the transcript was not or barely detected in epithelial cells. On GD 15.5, Crhr2b expression level was higher in mesenchymal cells than in epithelial cells, while on GD 17.5 the opposite situation was observed. Crhr2b mRNA was not detected in all samples. Crhr1 and Crhr2b mRNA levels were lower in cell cultures than in whole fetal lungs, similarly to Crh (data not shown). The expression of Crhbp was higher in epithelial cells than in fibroblasts on GD 15.5 and 17.5, while Pomc, Mc2r, and Nr3c1 are preferentially expressed in fibroblasts on GD 15.5 and in epithelial cells on GD 17.5 (Figure 4D). Expression levels of these last four genes were similar between cell cultures and total lung pools (data not shown).
Figure 4

Relative mRNA expression levels of HPA axis-related genes in differential cell cultures derived from fetal mouse lungs. Crh, Crhbp, Crhr1, Crhr2b, Pomc, Mc2r, Cyp21a1, Cyp11b1, and Nr3c1 were quantified by QPCR in fibroblast-enriched and in epithelial cell-enriched primary cultures originating from GD 15.5 and 17.5 fetal mouse lungs. Representative cultures of mesenchymal cells (A) and epithelial cells (B) are presented. Expression ratios of Krt18 (cytokeratin 18; epithelial cell marker) on Vim (vimentin; mesenchymal cell marker) were assessed to confirm cell enrichment (C). For each studied gene, ratios of expression levels in epithelial cells over expression levels in mesenchymal cells are presented (D). Genes for which all or some of the samples were negative are presented in the inset. Values that are over the dashed line represent higher expression level in epithelial cell-enriched cultures. ND, not detected; E, epithelial cell-enriched cultures; F, fibroblast-enriched cultures.

Expression of Cyp21a1 and Cyp11b1 in fetal mouse lungs and fetal lung primary cell cultures

Cyp21a1 and Cyp11b1 encode the last two steroidogenic enzymes involved in de novo corticosterone synthesis [36, 37]. Cyp11b1 expression was previously observed on GD 15.5, but not on GD 16.5, 17.5, and 18.5 in the fetal lung [22]. There was no available data on expression of Cyp21a1 after GD 15.5. We detected Cyp21a1 mRNA in fetal lung pools and in lung explants obtained on GD 17.5 (data not shown). Interestingly, Cyp21a1 mRNA was detected at much higher levels in primary cell cultures than in non-incubated whole lung samples and lung explants. Indeed, Cyp21a1 mRNA levels were ~15 and ~40 fold higher in fibroblast- and in epithelial cell-enriched cultures, respectively, than in lung explants (data not shown), and were higher in epithelial fractions than in fibroblast fractions on both GD 15.5 and 17.5 (Figure 4D). In agreement with previous data, Cyp11b1 mRNA was not detected in lung explants obtained on GD 17.5 in the present study. However, Cyp11b1 mRNA was surprisingly detected at relatively high levels in cell cultures, as Cyp21a1.

The potential effect of reciprocal exposure of epithelial- and mesenchymal-enriched cell cultures to their respective secreted factors on gene expression of Crh, Crhr1, Crhr2β, Cyp21a1, and Cyp11b1 was addressed. Target gene mRNA levels were quantified in epithelial- and mesenchymal-enriched cells after co-culture using porous filters (0.1 μm) during 96 h (n = 16 fetal lungs from 3 litters). Crhr2β mRNA level was 4-fold higher in co-cultured fibroblasts than in fibroblasts cultured alone. For the other analyzed genes, results obtained from co-cultured cells were similar to those from separated cells (data not shown).

Incubation of fetal mouse lung explants in the presence of CRH or ACTH, and determination of glucocorticoid formation

GD 15.5 and 17.5 lung explants were incubated in the presence of CRH or ACTH to evaluate the potential modulatory roles of these hormones on mRNA levels of Pomc, Star, Hsd3b1, Cyp21a1, and Cyp11b1. The fetal sex was not considered for the reasons exposed above. No effect of CRH or ACTH was observed on GD 15.5 on the expression level of any of the studied genes (data not shown). On GD 17.5, a significant stimulatory effect of CRH (n = 4, ANOVA, p = 0.0307; Tukey's test Ctl vs CRH, p < 0.05) was observed on Cyp21a1 mRNA levels (Figure 5). No significant effect was observed on Pomc, Star, and Hsd3b1 expression. To determine whether the CRH-induced increase in Cyp21a1 expression leads to increased enzymatic activity, we measured the level of newly-formed tritiated deoxycorticosterone in control and CRH-treated fetal lung explants isolated on GD17.5 using tritiated progesterone as substrate. Unlabeled deoxycorticosterone was added to reduce metabolization of newly-formed tritiated deoxycorticosterone. Accumulation of tritiated deoxycorticosterone was detected in all samples, and a non-statistically significant 25% increase of deoxycorticosterone production was observed in CRH-treated samples compared to controls (paired t-test, p = 0.36) (data not shown). No corticosterone accumulation was detected.
Figure 5

Effects of exogenous CRH or ACTH on expression levels of Pomc , Star , Hsd3b1 , and Cyp21a1 in mouse fetal lung explants. Fetal lungs were harvested on GD 17.5 and incubated 8h in the presence of 10-7 M CRH or 10-7 M ACTH. Messenger RNA levels of Pomc, Star, Hsd3b1, and Cyp21a1 were measured by QPCR in control and treated lungs. Data are presented as ratios of treated samples over control samples ± SEM. Experiments were performed with 1 to 3 fetal lungs per condition per litter (n = 4 litters), and statistical analysis was performed using one-way ANOVA with randomized-block design (samples within each litter were matched). *, P < 0.05

Discussion

We report expression of HPA axis-related genes in the fetal lung during late gestation, a period that includes the surge of surfactant synthesis occurring on GD 17 in the mouse. More precisely, we present expression profiles of Crh, Crhr1, Crhr2b, Crhbp, Pomc, Mc2r, and Nr3c1 and we also report marked co-expression of Mc2r with genes encoding for glucocorticoid synthesizing enzymes from cholesterol on GD 15.5. We show that Crhr1 and Pomc mRNAs are localized in cells surrounding proximal epithelia where iACTH is detected on GD 15.5 and 16.5, and that a major switch in expression sites toward epithelial cells of distal zones occurred between GD 15.5 and 17.5 for all the studied genes. In addition, a significant CRH-modulated increase in Cyp21a1 expression was observed in fetal lung explants isolated on GD 17.5 as well as a deoxycorticosterone production by fetal lung explants. Even though our data do not suggest a functional HPA axis regulating the previously reported pathway of glucocorticoid synthesis on GD 15, they support roles for HPA axis-related components, as well as autocrine/paracrine actions of CRH and ACTH, in developing lungs.

In several species, a local metabolism of glucocorticoids through the action of 11β-hydroxysteroid dehydrogenases (11βHSDs) was shown in the developing lung where it leads to a net increased formation of active glucocorticoids by the predominant 11βHSD type 1 activity [3842]. It was also reported that the fetal mouse lung expresses all the genes involved in glucocorticoid synthesis from cholesterol [22]. High expression of the latter genes was observed in several litters on GD 15 but only in male or female lung pools according to the analyzed litter, and this occurred before an important rise in Hsd11b1 expression [22]. Interestingly, in the present study, Mc2r was highly expressed in the same pools where the genes involved in glucocorticoid synthesis from cholesterol showed high expression levels, thus suggesting a role for Mc2r in the control of the "adrenal" pathway of glucocorticoid synthesis in the fetal lung. Accordingly, expression of Mrap was detected in fetal lung samples, the expression of this gene being necessary for MC2R signaling [34]. We localized a weak Mc2r mRNA signal in distal epithelial cells and in the mesenchyme on GD 15.5, while staining in epithelial cells was more intense on GD 17.5. MC2R was previously detected by immunohistochemistry in fetal mouse lungs from GD 11.5 to 14.5 in the bronchial epithelium and in the mesenchyme [15]. Taken together, these observations suggest that the site of Mc2r expression varies according to gestational time. Expression of Mc2r has been shown to be regulated temporally in the fetal testis [43], as in the fetal lung.

In the present study, incubation of lung explants isolated on GD 15.5 with CRH or ACTH did not up-regulate the genes involved in the "adrenal" pathway of glucocorticoid synthesis. A postulated narrow window of CRH and/or ACTH receptivity may explain the absence of stimulation. Indeed, the fast progression of tissue development observed in the mouse where gestation is completed after only 19 days adds to the difficulty to characterize transitory events occurring within a very narrow developmental time window. Alternatively, it is not excluded that the previously reported transient co-expression of the five genes of the "adrenal" pathway may not be dependant on the presence of CRH and/or ACTH. Nevertheless, a significant increase in Cyp21a1 mRNA expression was observed in lung explants isolated on GD 17.5 following incubation with CRH, along with a 25% increased deoxycorticosterone production (p = 0.36). The high expression levels previously observed on GD 15 for the genes of the cascade were not reached in both control and stimulated lung explants in the present study, suggesting that the absent or modest activation of expression reported here for these genes is not a consequence of a saturated system caused by endogenous CRH and ACTH production.

After GD 15.5, 21-hydroxylase may not be involved in corticosterone synthesis since Cyp11b1 mRNA is neither expressed in intact tissue [22] nor stimulated following CRH or ACTH incubations in lung explants (Figure 5). A common observation to both adult mouse lung [21] and fetal lung after GD 15.5 is that expression of Cyp11a1 and Cyp21a1, but not that of Cyp11b1, occur. Interestingly, the immediate corticosterone precursor, deoxycorticosterone, produced from progesterone by 21-hydroxylase, was shown to have a low glucocorticoid effect [44, 45]. In the present study, steroidogenic activity experiments showed deoxycorticosterone production by fetal lungs through 21-hydroxylase activity, as also reported in [46]. In addition, based on the reported affinity of deoxycorticosterone for the mineralocorticoid receptor [47] and on the very low aldosterone synthase mRNA level in fetal lungs ([22] and data not shown), one would suggest that this steroid could have also mineralocorticoid effects in the lung.

Incubation of GD 17.5 lung explants in the presence of ACTH led to a non-significant 1.5-fold increase in Cyp21a1 expression, and the stimulatory effect of CRH on Cyp21a1 did not involve an increase in Pomc mRNA expression. Therefore, if CRH acted through ACTH, it would rather be at another regulatory level, such as prohormone processing or hormone release. A similar slight but not statistically significant effect of ACTH was observed on the capability of thymic epithelial cells to stimulate a glucocorticoid-regulated reporter system [21]. Further studies are needed to clarify whether a local HPA axis-like regulatory pathway is functional in the fetal lung as it is the case in the adult skin, where glucocorticoid production has been shown to be regulated by a local cascade of CRH and ACTH production and signaling [19].

In epithelial- and mesenchymal-enriched primary cell cultures, Crh, Crhr1, and Crhr2b were not or barely detected whereas Cyp11b1 and Cyp21a1 were detected at relatively high levels. A different situation was observed in total lungs for these five genes. Such noticeable differences in expression levels between primary cell cultures and total lungs were not observed for the other studied genes. These discrepancies should not arise from cell enrichment but rather from dysregulation of regulatory pathways that are active in the whole tissue because: Crh expression was undetectable in both epithelial-enriched and mesenchymal-enriched cell cultures but was clearly detected in vivo by in situ hybridization in cell types that are represented in cell cultures, and; mRNA levels of Cyp11b1 were elevated in both epithelial-enriched and mesenchymal-enriched cell cultures in contrast to whole lungs where only barely detectable levels were detected. Accordingly, cell-cell communication between mesenchymal and epithelial cells was reported in the developing lung [48], and may be involved in the in vivo regulation of the above-mentioned genes. Results from our co-culture experiments suggest that such a potential regulation is not explained alone by secreted factors from epithelial and mesenchymal cells. A similar situation was also observed in the lung where glucocorticoids had differential effects on the expression of Nr3c1 in fetal lung primary cell cultures compared to whole fetal lung tissues in the rat [49].

Our data suggest paracrine and/or autocrine regulation and action of CRH and POMC-related peptide(s) in the developing lung. However, an effect of circulating ligands on specific CRH and ACTH receptors expressed in the lung is not excluded. Noteworthily, changes in expression sites of the studied receptors also suggest different functions according to the developmental status of the tissue.

Crh mRNA was detected at higher levels in fetal lung samples than in control tissues, including the adult lung, which is consistent with a specific role for CRH in lung development (Figure 1). Accordingly, detection of Crh mRNA by in situ hybridization was reported on GD 12.5 in the mouse lung around branching bronchioles with an increase until GD 15.5, followed by a constant expression level until GD 17.5, while no signal was detected on GD 18.5 and postnatal day 1 [11]. However, the change in Crh expression sites that we present here was not reported in that study. Interestingly, in a previous microarray analysis in mouse fetal lungs, Crh expression was significantly higher in lungs from males exposed to the anti-androgen flutamide compared to control males (~50% increase, p < 0.05), suggesting an inhibitory effect of endogenous androgens on Crh expression [27]. We observed by QPCR that Crh mRNA levels tended to increase between GD 15.5 and 17.5, while levels of Crhbp tended to decrease. This is suggestive of an increased CRH bioactivity considering the inhibitory action of CRHBP on CRH signaling [33]. Crhbp was the only gene showing a significant sex difference in expression in the present study. Interestingly, a sex dimorphism in Crhbp expression was reported in the mouse pituitary gland [50]. Crhr1 mRNA was detected at very low levels in fetal lungs. However, the fact that its expression is limited to a low proportion of cells may explain the low mRNA levels measured from total lung extracts. Similarly to our Crhr1 expression data, an important interindividual variability in CRHR1 mRNA levels was observed in developing fetal baboon lungs, with detection in about 30% of samples on GD 125 (term ~180 days) [14].

Interestingly, Crhr1 and Pomc mRNAs are co-localized on GD 15.5 and 16.5 in cells surrounding the proximal epithelium. In contrast, this staining pattern was not observed on GD 17.5. These results suggest that CRHR1 signaling could lead to ACTH production in a developmental time-specific manner. However, the question whether MC2R ligand is produced in the lung or is imported from the circulation still remains. The detection of immunoreactive ACTH in cells adjacent to those expressing Pomc mRNA (GD 15.5-16.5) and in Pomc mRNA-positive cells (GD 17.5) suggests a paracrine/autocrine action of ACTH. Gene expression of several prohormone convertases [51], namely FURIN, endoprotease PACE4, proprotein convertase subtilisin/kexin (PCSK) type 5, and PCSK7 were detected in the developing mouse lung at GD 17.0 and 18.0 by DNA microarrays [27]. Pc1/3, which encodes the prohormone convertase 1/3 that is associated to ACTH production in the pituitary, was not detected in this gene profiling experiment. However, FURIN and PACE4 have been shown to yield ACTH from POMC [52].

This report shows a transition in expression sites between GD 15.5 and 17.5 for all the studied genes (Figures 2 and 3). These developmental time-specific expression profiles are partly supported by QPCR data obtained from mesenchymal- and epithelial-enriched primary cell cultures (Figure 4). On GD 17.5, expression of every gene was mainly localized in the distal epithelium. This pattern of expression is interesting in the context of lung maturation since the surge of surfactant production occurs on GD 17 in some epithelial cells of this epithelium. Thus, a role for CRH/ACTH in maturation and/or development of the distal epithelium is envisaged.

Conclusions

Temporal and spatial expression patterns of HPA axis-related genes in fetal lungs during late gestation suggest local roles for CRH and POMC/ACTH in lung development. Our data are likely to lead to valuable insights in relation to lung diseases originating from lung immaturity.

Declarations

Acknowledgements

The authors would like to thank Dr Tommy Seaborn and Eric Boucher for critical reading of the manuscript. We also thank Dr Denis Nadeau for helpful advices on cell culture preparation. This work was supported by the Canadian Institutes of Health Research (CIHR) (grant numbers IC87816 and IC90831 to YT).

Authors’ Affiliations

(1)
Reproduction, Perinatal Health, and Child Health, CHUQ Research Center
(2)
Centre de Recherche en Biologie de la Reproduction (CRBR), Laval University
(3)
Department of Obstetrics and Gynecology, Faculty of Medicine, Laval University

References

  1. Papadimitriou A, Priftis KN: Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation. 2009, 16: 265-271. 10.1159/000216184.View ArticlePubMedGoogle Scholar
  2. Mastorakos G, Ilias I: Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003, 997: 136-149. 10.1196/annals.1290.016.View ArticlePubMedGoogle Scholar
  3. Majzoub J: Corticotropin-releasing hormone physiology. Eur J Endocrinol. 2006, 155: S71-S76. 10.1530/eje.1.02247.View ArticleGoogle Scholar
  4. Raffin-Sanson ML, de Keyzer Y, Bertagna X: Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol. 2003, 149: 79-90. 10.1530/eje.0.1490079.View ArticlePubMedGoogle Scholar
  5. Bicknell AB: The tissue-specific processing of pro-opiomelanocortin. J Neuroendocrinol. 2008, 20: 692-699. 10.1111/j.1365-2826.2008.01709.x.View ArticlePubMedGoogle Scholar
  6. Fowden AL, Forhead AJ: Endocrine regulation of feto-placental growth. Horm Res. 2009, 72: 257-265. 10.1159/000245927.View ArticlePubMedGoogle Scholar
  7. Grier DG, Halliday HL: Effects of glucocorticoids on fetal and neonatal lung development. Treat Respir Med. 2004, 3: 295-306. 10.2165/00151829-200403050-00004.View ArticlePubMedGoogle Scholar
  8. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA: Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol. 2001, 32: 76-91. 10.1002/ppul.1092.View ArticlePubMedGoogle Scholar
  9. Muglia LJ, Jacobson L, Weninger SC, Karalis KP, Jeong K, Majzoub JA: The physiology of corticotropin-releasing hormone deficiency in mice. Peptides. 2001, 22: 725-731. 10.1016/S0196-9781(01)00385-0.View ArticlePubMedGoogle Scholar
  10. Cole TJ, Solomon NM, Van Driel R, Monk JA, Bird D, Richardson SJ, Dilley RJ, Hooper SB: Altered epithelial cell proportions in the fetal lung of glucocorticoid receptor null mice. Am J Respir Cell Mol Biol. 2004, 30: 613-619. 10.1165/rcmb.2003-0236OC.View ArticlePubMedGoogle Scholar
  11. Keegan CE, Herman JP, Karolyi IJ, O'Shea KS, Camper SA, Seasholtz AF: Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain. Endocrinology. 1994, 134: 2547-2555. 10.1210/en.134.6.2547.PubMedGoogle Scholar
  12. Dotzler SA, Digeronimo RJ, Yoder BA, Siler-Khodr TM: Distribution of corticotropin releasing hormone in the fetus, newborn, juvenile, and adult baboon. Pediatr Res. 2004, 55: 120-125. 10.1203/01.PDR.0000100460.00639.F4.View ArticlePubMedGoogle Scholar
  13. Wood CE, Barkoe D, The A, Newman H, Cudd TA, Purinton S, Castro MI: Fetal pulmonary immunoreactive adrenocorticotropin: molecular weight and cellular localization. Regul Pept. 1998, 73: 191-196. 10.1016/S0167-0115(98)00004-4.View ArticlePubMedGoogle Scholar
  14. Emanuel RL, Torday JS, Asokananthan N, Sunday ME: Direct effects of corticotropin-releasing hormone and thyrotropin-releasing hormone on fetal lung explants. Peptides. 2000, 21: 1819-1829. 10.1016/S0196-9781(00)00343-0.View ArticlePubMedGoogle Scholar
  15. Nimura M, Udagawa J, Hatta T, Hashimoto R, Otani H: Spatial and temporal patterns of expression of melanocortin type 2 and 5 receptors in the fetal mouse tissues and organs. Anat Embryol (Berl). 2006, 211: 109-117. 10.1007/s00429-005-0066-9.View ArticleGoogle Scholar
  16. Boorse GC, Denver RJ: Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. Gen Comp Endocrinol. 2006, 146: 9-18. 10.1016/j.ygcen.2005.11.014.View ArticlePubMedGoogle Scholar
  17. Batanero E, de Leeuw FE, Jansen GH, van Wichen DF, Huber J, Schuurman HJ: The neural and neuro-endocrine component of the human thymus. II. Hormone immunoreactivity. Brain Behav Immun. 1992, 6: 249-264. 10.1016/0889-1591(92)90047-R.View ArticlePubMedGoogle Scholar
  18. Aird F, Clevenger CV, Prystowsky MB, Redei E: Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc Natl Acad Sci USA. 1993, 90: 7104-7108. 10.1073/pnas.90.15.7104.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Slominski A, Wortsman J, Tuckey RC, Paus R: Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol. 2007, 265-266: 143-149. 10.1016/j.mce.2006.12.012.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Davies E, MacKenzie SM: Extra-adrenal production of corticosteroids. Clin Exp Pharmacol Physiol. 2003, 30: 437-445. 10.1046/j.1440-1681.2003.03867.x.View ArticlePubMedGoogle Scholar
  21. Pazirandeh A, Xue Y, Rafter I, Sjovall J, Jondal M, Okret S: Paracrine glucocorticoid activity produced by mouse thymic epithelial cells. Faseb J. 1999, 13: 893-901.PubMedGoogle Scholar
  22. Provost PR, Tremblay Y: Genes involved in the adrenal pathway of glucocorticoid synthesis are transiently expressed in the developing lung. Endocrinology. 2005, 146: 2239-2245. 10.1210/en.2005-0077.View ArticlePubMedGoogle Scholar
  23. Buckingham S, Avery ME: Time of appearance of lung surfactant in the foetal mouse. Nature. 1962, 193: 688-689. 10.1038/193688a0.View ArticlePubMedGoogle Scholar
  24. Oldenborg V, Van Golde LM: The enzymes of phosphatidylcholine biosynthesis in the fetal mouse lung. Effects of dexamethasone. Biochim Biophys Acta. 1977, 489: 454-465.View ArticlePubMedGoogle Scholar
  25. Brehier A, Rooney SA: Phosphatidylcholine synthesis and glycogen depletion in fetal mouse lung: developmental changes and the effects of dexamethasone. Exp Lung Res. 1981, 2: 273-287. 10.3109/01902148109052323.View ArticlePubMedGoogle Scholar
  26. Farrell PM, Avery ME: Hyaline membrane disease. Am Rev Respir Dis. 1975, 111: 657-688.PubMedGoogle Scholar
  27. Bresson E, Seaborn T, Cote M, Cormier G, Provost PR, Piedboeuf B, Tremblay Y: Gene expression profile of androgen modulated genes in the murine fetal developing lung. Reprod Biol Endocrinol. 2010, 8: 2-10.1186/1477-7827-8-2.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Plante J, Simard M, Rantakari P, Cote M, Provost PR, Poutanen M, Tremblay Y: Epithelial cells are the major site of hydroxysteroid (17beta) dehydrogenase 2 and androgen receptor expression in fetal mouse lungs during the period overlapping the surge of surfactant. J Steroid Biochem Mol Biol. 2009, 117: 139-145. 10.1016/j.jsbmb.2009.08.006.View ArticlePubMedGoogle Scholar
  29. Pelletier G, Leclerc R, Labrie F, Cote J, Chretien M, Lis M: Immunohistochemical localization of beta-lipotropic hormone in the pituitary gland. Endocrinology. 1977, 100: 770-776. 10.1210/endo-100-3-770.View ArticlePubMedGoogle Scholar
  30. Provost PR, Simard M, Tremblay Y: A link between lung androgen metabolism and the emergence of mature epithelial type II cells. Am J Respir Crit Care Med. 2004, 170: 296-305. 10.1164/rccm.200312-1680OC.View ArticlePubMedGoogle Scholar
  31. Simard M, Plante J, Boucher M, Provost PR, Tremblay Y: Type 2 and 5 17beta-hydroxysteroid dehydrogenases and androgen receptor in human fetal lungs. Mol Cell Endocrinol. 2009Google Scholar
  32. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3: RESEARCH0034-10.1186/gb-2002-3-7-research0034.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Westphal NJ, Seasholtz AF: CRH-BP: the regulation and function of a phylogenetically conserved binding protein. Front Biosci. 2006, 11: 1878-1891. 10.2741/1931.View ArticlePubMedGoogle Scholar
  34. Hinkle PM, Sebag JA: Structure and function of the melanocortin2 receptor accessory protein (MRAP). Mol Cell Endocrinol. 2009, 300: 25-31. 10.1016/j.mce.2008.10.041.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Drouin J, Nemer M, Charron J, Gagner JP, Jeannotte L, Sun YL, Therrien M, Tremblay Y: Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids. Genome. 1989, 31: 510-519.View ArticlePubMedGoogle Scholar
  36. Miller WL: Molecular biology of steroid hormone synthesis. Endocr Rev. 1988, 9: 295-318. 10.1210/edrv-9-3-295.View ArticlePubMedGoogle Scholar
  37. Stocco DM, Clark BJ: Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996, 17: 221-244.PubMedGoogle Scholar
  38. Torday JS, Smith BT, Giroud CJ: The rabbit fetal lung as a glucocorticoid target tissue. Endocrinology. 1975, 96: 1462-1467. 10.1210/endo-96-6-1462.View ArticlePubMedGoogle Scholar
  39. Torday JS, Olson EB, First NL: Production of cortisol from cortisone by the isolated, perfused fetal rabbit lung. Steroids. 1976, 27: 869-880. 10.1016/0039-128X(76)90145-8.View ArticlePubMedGoogle Scholar
  40. Torday JS: The sex difference in type II cell surfactant synthesis originates in the fibroblast in vitro. Exp Lung Res. 1984, 7: 187-194. 10.3109/01902148409087912.View ArticlePubMedGoogle Scholar
  41. Torday JS, Post M, Smith BT: Compartmentalization of 11-oxidoreductase within fetal lung alveolus. Am J Physiol. 1985, 249: C173-176.PubMedGoogle Scholar
  42. Thompson A, Han VK, Yang K: Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development. J Steroid Biochem Mol Biol. 2004, 88: 367-375. 10.1016/j.jsbmb.2003.12.014.View ArticlePubMedGoogle Scholar
  43. O'Shaughnessy PJ, Fleming LM, Jackson G, Hochgeschwender U, Reed P, Baker PJ: Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology. 2003, 144: 3279-3284. 10.1210/en.2003-0277.View ArticlePubMedGoogle Scholar
  44. Hellal-Levy C, Couette B, Fagart J, Souque A, Gomez-Sanchez C, Rafestin-Oblin M: Specific hydroxylations determine selective corticosteroid recognition by human glucocorticoid and mineralocorticoid receptors. FEBS Lett. 1999, 464: 9-13. 10.1016/S0014-5793(99)01667-1.View ArticlePubMedGoogle Scholar
  45. Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL: International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev. 2006, 58: 782-797. 10.1124/pr.58.4.9.View ArticlePubMedGoogle Scholar
  46. Boucher E, Devillers A, Provost PR, Tremblay Y: Glucocorticoid synthesis pathways in pre- and post-natal lungs [abstract]. Endocr Rev. 2010, 31: S1732-Google Scholar
  47. Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, Diederich S, Bahr V: Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol. 2002, 146: 789-799. 10.1530/eje.0.1460789.View ArticlePubMedGoogle Scholar
  48. Kumar VH, Lakshminrusimha S, El Abiad MT, Chess PR, Ryan RM: Growth factors in lung development. Adv Clin Chem. 2005, 40: 261-316. full_text.View ArticlePubMedGoogle Scholar
  49. Sweezey NB, Ghibu F, Gagnon S, Schotman E, Hamid Q: Glucocorticoid receptor mRNA and protein in fetal rat lung in vivo: modulation by glucocorticoid and androgen. Am J Physiol. 1998, 275: L103-109.PubMedGoogle Scholar
  50. Speert DB, SJ MC, Seasholtz AF: Sexually dimorphic expression of corticotropin-releasing hormone-binding protein in the mouse pituitary. Endocrinology. 2002, 143: 4730-4741. 10.1210/en.2002-220556.View ArticlePubMedGoogle Scholar
  51. Nillni EA: Regulation of prohormone convertases in hypothalamic neurons: implications for prothyrotropin-releasing hormone and proopiomelanocortin. Endocrinology. 2007, 148: 4191-4200. 10.1210/en.2007-0173.View ArticlePubMedGoogle Scholar
  52. Seidah NG, Benjannet S, Hamelin J, Mamarbachi AM, Basak A, Marcinkiewicz J, Mbikay M, Chretien M, Marcinkiewicz M: The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann N Y Acad Sci. 1999, 885: 57-74. 10.1111/j.1749-6632.1999.tb08665.x.View ArticlePubMedGoogle Scholar

Copyright

© Simard et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement